Biovest International Inc. (BVTI) - OTC Markets
BVTI is defunct.
Company Description
We are a biotechnology company focusing primarily on the development of BiovaxID™, a patient-specific anti-cancer vaccine focusing on the treatment of follicular non-Hodgkins lymphoma, or follicular NHL. Follicular NHL is a cancer of the lymphatic system that results when the body’s follicle... More
Sector: Healthcare
Industry: Biotechnology
Country: United States